However, in our model no fibrosis was observed, potentially due to the length of observation time; moreover, Edn1 is also a potent vasoconstrictor peptide, and its dysregulation has been implicated in coronary microvascular dysfunction, non-small cell lung cancer development and progression [36, 37]. This evidence concerns the gene EDN1 and non-small cell lung carcinoma.